Among the conventional molecular markers commonly investigated for diagnosis and management of each one of the three considered pathologies—OD, AML, and BG—IDH1 R132H represents the only genetic anomaly shared by all three diseases. The gene discussed is IDH1; the disease is acute myeloid leukemia.